Purchase Order 75N95023P00525
Award Date 8/21/23
Potential Completion Date 10/20/23
Potential Value $46K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Kansas City, KS 66103, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a purchase order awarded by the U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse (NIDA) to Xenotech LLC, a small disadvantaged business doing business as Sekisui-Xenotech. The $41,496 firm fixed price contract is for the delivery of 300 vials (1mL each) of "Mixed Gender Human Liver Microsomes" to support the National Center for Advancing Translational Sciences (NCATS) Tox21 program's research on drug metabolism and...
- This purchase order contract was awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Life Technologies Corporation for the delivery of 50 vials of human spheroid-qualified hepatocytes. As described in the original solicitation, these liver cells will support the National Institute on Drug Abuse's Antiviral Program for Pandemics by enabling the continued identification of direct-acting antivirals and development of microphysiological systems...
- This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $24,262.29 contract is for the delivery of primary human hepatocytes, which are a critical reagent used in biomedical research supported by NCATS. This contract is not associated with any set-aside...
- This is a fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of cryopreserved human hepatocytes, which are used to support biomedical research, medical readiness, and other federal initiatives. The contract has a ceiling value of $127,649.76 and a completion date of August 7, 2020. Life Technologies serves as a prime contractor...
- This firm-fixed-price purchase order contract was awarded by the National Institute on Drug Abuse, a civilian agency within the U.S. Department of Health and Human Services, to Insphero Inc., a foreign-owned, for-profit manufacturer of advanced 3D cell culture technologies. The $46,829.63 contract tasks Insphero with providing 3D liver microtissues composed of human primary hepatocytes and other liver cells, which are used for drug-induced liver injury assays and toxicity testing. These...
- This is a $90,414 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, to Insphero Inc., a foreign-owned, for-profit manufacturer of 3D cell culture technologies and in vitro models. The contract is for a Liver Assay in Liver Spheroids to evaluate the toxicity of short interfering RNA (siRNA) and antisense oligonucleotides (ASOs), which are increasingly being used as...
- This is a firm fixed price contract awarded by the National Institute on Drug Abuse (NIDA), an agency of the U.S. Department of Health and Human Services, to Xenotech LLC, doing business as Sekisui-Xenotech, for in vitro metabolism and metabolite quantification services. The period of performance is from July 6, 2015 to July 5, 2020, with a ceiling value of $1,391,921.30. This contract is not set aside for any specific business category. Xenotech, a small disadvantaged business, specializes in...
- The Food and Drug Administration (FDA) awarded a $91,630 firm-fixed-price purchase order contract to Discovery Life Sciences, LLC, a small disadvantaged business, for the delivery of 110 vials of primary cryopreserved human hepatocytes. This requirement supports the FDA's National Center of Toxicological Research (NCTR) Division of Biochemical Toxicology's research into drug toxicity and metabolic enzymes. The contract has a period of performance through August 19, 2024 and was awarded under a...
- This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to BioIVT, LLC for the procurement of various Hepatopac sample well plates, including human, mouse, and stromal plates, as well as maintenance and application media. The total ceiling value of the contract is $27,249.00, with an anticipated 60-day delivery after receipt of order. The purchase order was awarded on a...
- This is a $18,166 firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Bioivt, LLC, a for-profit limited liability company, for the delivery of human and mouse hepatopac plates. The contract has a period of performance through November 2, 2024 and was not set aside for any particular business type. Bioivt is a leading global provider of biological specimens and has supported medical research programs across various...